Hakan Cakmak1, Audra Katz, Marcelle I Cedars, Mitchell P Rosen. 1. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California.
Abstract
OBJECTIVE: To determine whether random-start controlled ovarian stimulation (COS), in which a patient is stimulated on presentation regardless of her menstrual-cycle phase, has outcomes similar to conventional early follicular phase-start COS for fertility preservation in cancer patients. DESIGN: Retrospective cohort study. SETTING: Academic medical center. PATIENT(S): Women recently diagnosed with cancer and in preparation for gonadotoxic therapy. INTERVENTION(S): Random- versus conventional-start COS. PRIMARY OUTCOME: number of mature oocytes retrieved; secondary outcomes: pattern of follicular development, oocyte yield, and fertilization rate. RESULT(S): The number of total and mature oocytes retrieved, oocyte maturity rate, mature oocyte yield, and fertilization rates were similar in random- (n = 35) and conventional-start (n = 93) COS cycles. No superiority was noted when comparing COS started in the late follicular (n = 13) or luteal phase (n = 22). The addition of letrozole, in the case of estrogen-sensitive cancers, did not adversely affect COS outcomes or oocyte maturity and competence in either random- or conventional-start protocols. CONCLUSION(S): Random-start COS is as effective as conventional-start COS in fertility preservation. This protocol would minimize delays and allow more patients to undergo fertility preservation and still proceed with cancer treatment within 2-3 weeks.
RCT Entities:
OBJECTIVE: To determine whether random-start controlled ovarian stimulation (COS), in which a patient is stimulated on presentation regardless of her menstrual-cycle phase, has outcomes similar to conventional early follicular phase-start COS for fertility preservation in cancerpatients. DESIGN: Retrospective cohort study. SETTING: Academic medical center. PATIENT(S): Women recently diagnosed with cancer and in preparation for gonadotoxic therapy. INTERVENTION(S): Random- versus conventional-start COS. PRIMARY OUTCOME: number of mature oocytes retrieved; secondary outcomes: pattern of follicular development, oocyte yield, and fertilization rate. RESULT(S): The number of total and mature oocytes retrieved, oocyte maturity rate, mature oocyte yield, and fertilization rates were similar in random- (n = 35) and conventional-start (n = 93) COS cycles. No superiority was noted when comparing COS started in the late follicular (n = 13) or luteal phase (n = 22). The addition of letrozole, in the case of estrogen-sensitive cancers, did not adversely affect COS outcomes or oocyte maturity and competence in either random- or conventional-start protocols. CONCLUSION(S): Random-start COS is as effective as conventional-start COS in fertility preservation. This protocol would minimize delays and allow more patients to undergo fertility preservation and still proceed with cancer treatment within 2-3 weeks.
Authors: A Balduzzi; J-H Dalle; K Jahnukainen; M von Wolff; G Lucchini; M Ifversen; K T Macklon; C Poirot; T Diesch; A Jarisch; D Bresters; I Yaniv; B Gibson; A M Willasch; R Fadini; L Ferrari; A Lawitschka; A Ahler; N Sänger; S Corbacioglu; M Ansari; R Moffat; A Dalissier; E Beohou; P Sedlacek; A Lankester; C D De Heredia Rubio; K Vettenranta; J Wachowiak; A Yesilipek; E Trigoso; T Klingebiel; C Peters; P Bader Journal: Bone Marrow Transplant Date: 2017-07-24 Impact factor: 5.483
Authors: Taylor Nordan; Ann M Thomas; Elizabeth S Ginsburg; Patrick Y Wen; Andrey V Dolinko; Pietro Bortoletto Journal: J Neurooncol Date: 2020-02-14 Impact factor: 4.130
Authors: Joceline V Vu; Natalia C Llarena; Samantha L Estevez; Molly B Moravek; Jacqueline S Jeruss Journal: J Surg Oncol Date: 2016-12-14 Impact factor: 3.454